Larvol Delta - Safety-and-Efficacy-of-Allogeneic-NK-Cell-Infusions-in-Patients-With-RelapsedRefractory-AML-and-High-Risk-MDS

DVX201 - Deverra Therapeutics

http://clinicaltrials.gov/ct2/show/NCT04901416

Jan 6, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next